Dr. Matthias Wiedenfels is a consultant in our corporate practice
Matthias is our industrial expert in our global healthcare practice and advises on takeover situations, M&A transactions and on all pharmaceutical and healthcare matters.
He is an expert in corporate governance, corporate strategy, compliance, corporate law and pharma law. As the former CEO of STADA Arzneimittel AG, he played a decisive role in the takeover of the company by Bain Capital and Cinven, and in many other major transactions.
As a co-author of the "Pharma und Life Science" handbook, Matthias is a recognised expert for pharma law and for compliance.
With his industrial expertise, his transactional experience and his management know-how, Matthias is strengthening our corporate and healthcare advisory practice for our clients.
Beside his consultancy role for Ashurst, Matthias is an investor and entrepreneur in the healthcare market.
Matthias studied law in Heidelberg, Montpellier and Freiburg. He was admitted to bar in 2001 and published a multitude of professional articles and handbooks. He speaks English and French and is an advisory board member on various national and international companies.
Latest Insights
Carousel: clicking the "Previous" or "Next" button changes the content between the buttons.
-
Legal development 
Update on suggested regulatory changes in the German hospital landscape
19 Mar 2024
Discover more -
Legal development
Update on the legislative initiative against supply shortages in drug
05 Apr 2023
Discover more